Genetic variants of the human H+/dipeptide transporter PEPT2: analysis of haplotype functions
about
Functional characterization of the peptide transporter PEPT2 in primary cultures of human upper airway epitheliumFrom bacteria to man: archaic proton-dependent peptide transporters at work.Genotyping panel for assessing response to cancer chemotherapy.Xenobiotic, bile acid, and cholesterol transporters: function and regulation.Intronic SNP in ESR1 encoding human estrogen receptor alpha is associated with brain ESR1 mRNA isoform expression and behavioral traitsThe pharmacogenomics of membrane transporters project: research at the interface of genomics and transporter pharmacology.A novel and rapid method of determining the effect of unclassified MLH1 genetic variants on differential allelic expressionDistribution of glycylsarcosine and cefadroxil among cerebrospinal fluid, choroid plexus, and brain parenchyma after intracerebroventricular injection is markedly different between wild-type and Pept2 null micePharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney.δ-Aminolevulinic acid dehydratase single nucleotide polymorphism 2 (ALAD2) and peptide transporter 2*2 haplotype (hPEPT2*2) differently influence neurobehavior in low-level lead exposed children.Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorderδ-Aminolevulinic acid dehydratase single nucleotide polymorphism 2 and peptide transporter 2*2 haplotype may differentially mediate lead exposure in male children.Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugsSerotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder.CYP2C9 promoter variable number tandem repeat polymorphism regulates mRNA expression in human livers.SLC15A2 genomic variation is associated with the extraordinary response of sorafenib treatment: whole-genome analysis in patients with hepatocellular carcinoma.Pharmacogenetics/genomics and personalized medicine.Extensive allelic variation in gene expression in populus F1 hybrids.Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications.Regulatory effects of genomic translocations at the human carboxylesterase-1 (CES1) gene locus.Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement.Allelic mRNA expression of sortilin-1 (SORL1) mRNA in Alzheimer's autopsy brain tissues.Population pharmacokinetic modeling of cefadroxil renal transport in wild-type and Pept2 knockout miceRegulatory polymorphisms in CYP2C19 affecting hepatic expressionPharmaceutical and pharmacological importance of peptide transporters.PhRMA white paper on ADME pharmacogenomics.Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human heart tissuesRole and relevance of PEPT2 in drug disposition, dynamics, and toxicityKCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST)Importance of Peptide transporter 2 on the cerebrospinal fluid efflux kinetics of glycylsarcosine characterized by nonlinear mixed effects modeling.Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissuesPolymorphisms of delta-aminolevulinic acid dehydratase (ALAD) and peptide transporter 2 (PEPT2) genes in children with low-level lead exposure.Evidence for extensive pleiotropy among pharmacogenes.Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity.Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.PRPF4 mutations cause autosomal dominant retinitis pigmentosa.Allelic expression of serotonin transporter (SERT) mRNA in human pons: lack of correlation with the polymorphism SERTLPR.Molecular mechanism of dipeptide and drug transport by the human renal H+/oligopeptide cotransporter hPEPT2.Variability in renal clearance of substrates for renal transporters in chinese subjects.Identification of two novel genes SLC15A2 and SLCO1B3 associated with maintenance dose variability of warfarin in a Chinese population.
P2860
Q28300707-EA76F439-9F63-4A7D-B31A-788193E7B9C2Q33237678-DE29E84F-106F-4C43-9856-DA669225E18EQ33343095-835965F6-0ACD-49B4-80AB-13CD839431C3Q33714593-12A899A8-6EFE-481A-B1CE-F2DFD9FDDEB4Q33803212-896674E4-5183-465B-932C-54433EBC1EF1Q34071782-AD7834A4-E4B8-471C-B861-A912250CDFBAQ34239761-AA593A60-472A-4F9E-B17B-5AE99C65B588Q34249833-8057746D-6FB3-4443-9B2E-A357777D84FCQ34777362-138D07FD-EEC4-4834-9172-E2D69142F500Q34921722-B1A97D36-9453-4ED7-8A89-58E2F71186C3Q35112181-ED5AB2C7-8990-45C5-90CA-FCA66C90728DQ35281605-8E9125F7-C14F-4239-8997-A7E1A5A9381CQ35642257-C2B39269-ECFA-450A-89E2-FD61B86837D9Q35851031-A1136ED3-F183-47A7-B43F-EB32D00BA147Q35913092-E606C25C-97BE-410D-93AB-16A018504051Q36140832-E7DAC6DD-F7FE-46B6-A223-0F23B6669DA0Q36294685-3DAF7798-8675-468E-8465-FDC6239832B9Q36416320-FCB19298-BE4B-45D0-BEE3-F41359F4BA32Q36700240-0F1493A4-DB28-41C2-871F-60FCBF10B1A6Q36767978-BE96E7F2-F536-4210-B332-C305A367E6CEQ36835168-2AC79AA1-C31B-4459-8A07-89E9788579C7Q37033708-90D73A9D-D3CF-49DE-8FF0-1C8F96006CA6Q37093326-23F7A89A-4136-43D6-87EC-D43BC1CC5D9AQ37127419-EA398E9C-DAAD-44FD-82AF-0E65FC66A965Q37139860-53AA79DC-C61D-4D0B-AF58-660F17B2F6DAQ37182212-F13568D6-43E8-4ED9-9E0E-60500590011DQ37208437-1616D802-DB62-4C61-AD6B-6E56EE704D45Q37258172-1565B65E-7FEF-485C-A142-5638B364B452Q37269329-CAB76C4F-1912-438F-BB70-3E84D8BA8603Q37327301-C5BBEA14-B39C-4DCC-947C-4615A74705C8Q37427023-932F7E3D-323E-433A-B4A0-99AD7D0DED7CQ37463597-459AD163-D0C4-4C68-95C9-5A3A65DECEFAQ37703583-CF9C72DB-D5EE-430A-8680-0C43AF96BDAAQ38396102-39047B3B-49EF-41C4-9A28-F5F7108103FEQ40392922-5D1BA795-A9F8-4CFC-B607-C0AB93B34588Q43422368-E3A566A8-108B-46F6-9A4B-2F243E2A645DQ44199559-B0C5590B-3C45-4054-87B9-350B1EB6E873Q46681459-40DFD311-728B-44E3-B076-84C73CF9326DQ46908022-39F28826-999C-4232-B0BA-EAA15B236C86Q47113473-17FE5813-AAEF-4290-BE3F-3BAF920893D9
P2860
Genetic variants of the human H+/dipeptide transporter PEPT2: analysis of haplotype functions
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Genetic variants of the human ...... nalysis of haplotype functions
@ast
Genetic variants of the human ...... nalysis of haplotype functions
@en
Genetic variants of the human ...... nalysis of haplotype functions
@nl
type
label
Genetic variants of the human ...... nalysis of haplotype functions
@ast
Genetic variants of the human ...... nalysis of haplotype functions
@en
Genetic variants of the human ...... nalysis of haplotype functions
@nl
prefLabel
Genetic variants of the human ...... nalysis of haplotype functions
@ast
Genetic variants of the human ...... nalysis of haplotype functions
@en
Genetic variants of the human ...... nalysis of haplotype functions
@nl
P2093
P356
P1476
Genetic variants of the human ...... nalysis of haplotype functions
@en
P2093
Carsten Uhd Nielsen
Julia Pinsonneault
Wolfgang Sadée
P304
P356
10.1124/JPET.104.073098
P407
P577
2004-12-01T00:00:00Z